CRDF · Forms 3, 4, 5
Insider trades at Cardiff Oncology, Inc.
No open-market insider buys or sells at Cardiff Oncology, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Cardiff Oncology, Inc. (CRDF) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Cardiff Oncology, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gary W Pace | Director | Buy | 687,285 | $1.46 | $1M | Form 4 | |
| Mani Mohindru | Chief Executive Officer | Buy | 34,364 | $1.46 | $50K | Form 4 | |
| Mani Mohindru | Chief Executive Officer | Buy | 24,703 | $1.21 | $30K | Form 4 | |
| Gary W Pace | Director | Buy | 30,000 | $1.22 | $37K | Form 4 | |
| James O Armitage | Director | Options or other derivatives | Form 4 | ||||
| Lale White | Director | Options or other derivatives | Form 4 | ||||
| Renee P Tannenbaum | Director | Options or other derivatives | Form 4 | ||||
| Rodney S Markin | Director | Options or other derivatives | Form 4 | ||||
| Gary W Pace | Director | Options or other derivatives | Form 4 | ||||
| Ajay Aggarwal | Chief Operating Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.